impaginato piccolo - Società Italiana di Parassitologia (SoIPa)
impaginato piccolo - Società Italiana di Parassitologia (SoIPa)
impaginato piccolo - Società Italiana di Parassitologia (SoIPa)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Parassitologia</strong> 50: 51-53, 2008<br />
Toxoplasmosis in pregnancy: evaluation of <strong>di</strong>agnostic<br />
methods<br />
V. Meroni, F. Genco<br />
Infectious Diseases Department University of Pavia, Foundation IRCCS Policlinico San Matteo Pavia<br />
Introduction<br />
Abstract. Toxoplasmosis in pregnancy is usually subclinic or associated with non specific symptoms.<br />
Diagnosis and timing of infection are usually based on serological tests. In this short review we tried to summarize<br />
the serological patterns we can encounter and to <strong>di</strong>scuss the interpretation of test results<br />
Toxoplasma gon<strong>di</strong>i is an obligate intracellular protozoan<br />
that infects almost a third of the world’s population.<br />
Primary infection with T. gon<strong>di</strong>i in pregnant<br />
women may result in congenital toxoplamosis via<br />
transplacental transmission. The extent of damage<br />
depends mainly on when the mother gets infected, with<br />
consequences being more severe during the early phases<br />
of gestation. However, transmission is more frequent<br />
during late pregnancy (Dunn et al., 1999).<br />
As parasitaemia lasts only few days and infection is<br />
often asymptomatic, the <strong>di</strong>agnosis relies mainly on<br />
serology (Montoya and Liesenfeld, 2004).<br />
Diagnosis of toxoplasmosis in pregnancy has two goals:<br />
to evaluate the immune status of the woman, and in<br />
case of acute infection, to date the time of infection. It<br />
is therefore advisable to perform serological tests<br />
before or at the beginning of pregnancy.<br />
Serological Tests<br />
Key words: toxoplasmosis in pregnancy, serological tests, prenatal <strong>di</strong>agnosis<br />
Given the kinetics of antibody production, the screening<br />
tests for toxoplasmosis are based on measurement<br />
of specific anti-Toxoplasma IgG and IgM antibo<strong>di</strong>es<br />
with automated tests, which usually have a good sensitivity<br />
and specificity.<br />
Anti–Toxoplasma IgG antibo<strong>di</strong>es are produced<br />
throughout life after infection. Detection in a single<br />
sample at any titre with any test is a marker of previous<br />
infection.<br />
IgM antibo<strong>di</strong>es are detected in recently acquired infections<br />
but may persist for more than a year. Furthermore<br />
false positive, aspecific reaction may be recorded in<br />
IgG negative patients.<br />
Four <strong>di</strong>fferent serological patterns may be seen<br />
(Montoya and Liesenfeld, 2004; Sensini 2006).<br />
Correspondence: Valeria Meroni<br />
Infectious Diseases Department University of Pavia,<br />
Foundation IRCCS Policlinico San Matteo Pavia,<br />
e-mail: v.meroni@smatteo.pv.it<br />
1-IgG negative IgM negative<br />
No immunity. Hygienic alimentary prophylaxis and<br />
monthly follow up (if possible until one month after<br />
delivery) in order to avoid seroconversion are advised.<br />
Indeed there is some evidence that health education<br />
may reduce the risk of seroconversion and consequently<br />
of congenital toxoplasmosis. (Gollub et al., 2008).<br />
In Italy, the screening test in pregnancy is not mandatory<br />
but National Health System pays for a preconceptional<br />
test and for the follow-up of negative women<br />
(DPR245 10/09/98) so most of pregnant women<br />
undergo the monthly controls.<br />
2-IgG positive IgM negative.<br />
Previous immunity, if the tests have been done before<br />
or at the beginning of pregnancy.<br />
No further sampling inclu<strong>di</strong>ng further pregnancies is<br />
required.<br />
In the third trimester, a negative IgM test cannot<br />
exclude an infection in the first trimester; in these cases<br />
it is necessary to perform other tests such as IgG avi<strong>di</strong>ty<br />
and further testing one month later to evaluate serological<br />
stability.<br />
3-IgG negative IgM positive.<br />
Early seroconversion or false positive result (Gussetti<br />
et al., 1990).<br />
In any seroconversion, IgG must must be produced, so<br />
it is mandatory to repeat a weekly sampling to detect<br />
IgG. If the patient has been treated, however, IgG production<br />
might be delayed and decreased. If this is the<br />
case, it is preferable to employ <strong>di</strong>fferent tests (IgG-IgM<br />
Immunoblot, cellular immunity tests ) to obtain a <strong>di</strong>agnosis<br />
as early as possible.<br />
If a seroconversion has been proved, by using ad<strong>di</strong>tional<br />
tests ,the clinician should prescribe the correct therapy.<br />
This also allows to advice the woman for prenatal<br />
<strong>di</strong>agnosis.<br />
If seroconversion is not confirmed ,treatment can be<br />
safely <strong>di</strong>scontinued..<br />
Immunoblot for IgG and IgM is a very specific test<br />
when purified antigens (not commercially available)<br />
are employed.<br />
The presence of 3 bands for IgG and two bands for IgM<br />
against 30-40 kD proteins can confirm seroconversion<br />
earlier than any other test (Sharma et al., 1983).